Darren M. Dasburg, P.E.

University of Maryland
CBO
Bringing over 43 years of technical operations experience in a variety of small and large molecule settings, Darren Dasburg departed AstraZeneca as Vice President Global PMO & Strategy in 2019 after his role as Site GM for the Boulder Manufacturing Center beginning in September 2015. He is currently in advancing start-ups for cell and gene therapy start-ups including current role as CEO Clarus Biologics

Previously, Darren held the position of Vice President MedI BioVentures building partnerships in Korea, Japan and China for biosimilar development. Before then, VP of Capacity Utilization with where he led the first of its kind capacity sharing arrangement to support bio-manufacturing production. Prior to that, he was a Founding Partner in a consulting venture where he provided executive management team leadership in the areas of technical operations, manufacturing operations, project management, and business strategy. Darren did his formative years and ultimately served as Vice President of Corporate Engineering with GlaxoSmithKline.

Darren holds a Bachelor’s of Science in Mechanical Engineering from Colorado State University and a MBA from Duke University’s Fuqua School of Business and advanced certificates in biotechnology from MIT. He is a licensed Professional Engineer in North Carolina and has worked on the ISPE Bio Mfg Conference since it’s inception.